Unither Pharmaceuticals, with seven manufacturing plants (France, USA, Brazil and China) four commercial offices and one R&D platform, is the worldwide leader in sterile unit-doses contract manufacturing.
Unither Pharmaceuticals manufactures several product lines, using highly innovative and competitive niche technologies such as: Liquid Stick-Pack, Sterile unit-dose (Blow Fill & Seal Technology), Powder Stick-Pack, Oral liquids and Suspensions, Suppositories and Pessaries, Effervescent tablets, Orodispersible Solutions and Extended Release formulations.
Our products are sold in more than 100 countries for an annual turnover of 320 million euros.
Our vision is to make affordable and user-friendly products that everyone in the world can use to improve their lives.
Our mission is to deliver innovative, competitive and sustainable solutions to our customers: pharmaceutical companies.
Our promise is to consider patients’ needs in order to make successful products for our pharmaceutical clients.
Unither Pharmaceuticals, avec ses sept usines de fabrication (France, USA, Brésil et Chine) ses quatre bureaux commerciaux et sa plateforme de R&D, est le leader mondial de la sous-traitance d’unidoses stériles.
Unither Pharmaceuticals fabrique plusieurs gammes de produits, à l’aide de technologies de niche très novatrices et concurrentielles, telles que : Unisticks® liquides, Unidoses stériles (technologie Blow Fill & Seal), Unisticks® poudre, Liquides, Suspensions et Solutions buvables, Suppositoires et Ovules, Comprimés effervescents, Formes orodispersibles et Formulations à libération modifiée.
Ces produits sont vendus dans plus de 100 pays pour un chiffre d’affaires annuel de 320 millions d’euros.
Notre mission est d’offrir des solutions innovantes, compétitives et durables à nos clients : sociétés pharmaceutiques.
Notre promesse est de prendre en compte les besoins du patient pour aider nos clients à faire de leurs produits un succès sur le marché.
Unither Pharmaceuticals manufactures several product lines, using highly innovative and competitive niche technologies such as: Liquid Stick-Pack, Sterile unit-dose (Blow Fill & Seal Technology), Powder Stick-Pack, Oral liquids and Suspensions, Suppositories and Pessaries, Effervescent tablets, Orodispersible Solutions and Extended Release formulations.
Our products are sold in more than 100 countries for an annual turnover of 320 million euros.
Our vision is to make affordable and user-friendly products that everyone in the world can use to improve their lives.
Our mission is to deliver innovative, competitive and sustainable solutions to our customers: pharmaceutical companies.
Our promise is to consider patients’ needs in order to make successful products for our pharmaceutical clients.
Unither Pharmaceuticals, avec ses sept usines de fabrication (France, USA, Brésil et Chine) ses quatre bureaux commerciaux et sa plateforme de R&D, est le leader mondial de la sous-traitance d’unidoses stériles.
Unither Pharmaceuticals fabrique plusieurs gammes de produits, à l’aide de technologies de niche très novatrices et concurrentielles, telles que : Unisticks® liquides, Unidoses stériles (technologie Blow Fill & Seal), Unisticks® poudre, Liquides, Suspensions et Solutions buvables, Suppositoires et Ovules, Comprimés effervescents, Formes orodispersibles et Formulations à libération modifiée.
Ces produits sont vendus dans plus de 100 pays pour un chiffre d’affaires annuel de 320 millions d’euros.
Notre mission est d’offrir des solutions innovantes, compétitives et durables à nos clients : sociétés pharmaceutiques.
Notre promesse est de prendre en compte les besoins du patient pour aider nos clients à faire de leurs produits un succès sur le marché.
Location: France, Ile-de-France, Paris
Employees: 1001-5000
Phone: +55 17 3321-0021
Founded date: 1993
Investors 6
| Date | Name | Website |
| - | Idinvest P... | idinvest.c... |
| - | Parquest C... | parquest.f... |
| - | Ardian | ardian.com |
| 27.04.2023 | NiXEN | nixen.com |
| - | Equistone ... | equistonep... |
| 22.05.2025 | Keensight ... | keensightc... |
Mentions in press and media 5
| Date | Title | Description |
| 30.11.2023 | Unither Pharmaceuticals celebrates 30 years of innovation and expertise | PARIS, Nov. 30, 2023 /PRNewswire/ -- Unither Pharmaceuticals, a leading CDMO (Contract Development and Manufacturing Organization), celebrates 30 years in business. In 1993, Unither Pharmaceuticals began operations by acquiring a 17-man pha... |
| 26.10.2022 | Ardian announces the sale of its stake in Unither Pharmaceuticals to a consortium led by the CEO Eric Goupil and comprising GIC, IK Partners, Keensight and Parquest | Ardian, a world leading private investment house, today announces the sale of its majority stake in Unither Pharmaceuticals ("Unither"), a global leader in the development and manufacturing of sterile unit-doses, to a consortium o... |
| 18.11.2016 | Term Sheet — Friday, November 18 | Et Cetera Gig Economy: On-demand startups—the ones bringing us grocery, housecleaning, parking, lawn mowing, and personal butlers with a tap on our smartphones—have been out of vogue with venture investors for most of this year. When Postma... |
| 17.11.2016 | Ardian enters into exclusive negotiations for the acquisitions of Unither, alongside management | Unither Pharmaceuticals, has become a globally renowned company for the development and manufacturing of sterile unit-doses, non-sterile liquids, liquid sticks, solid and semi-solid medications for the pharmaceutical and generic drug indust... |
| 02.11.2011 | Unither Pharmaceuticals Acquired by Barclays Private Equity | Unither Pharmaceuticals, a French manufacturer of dosage forms for pharmaceutical laboratories, and generic products, has been acquired by Barclays Private Equity for an undisclosed sum. In the buyout, Barclays Private Equity has acquired a... |